Progyny Inc (PGNY)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Total assets US$ in thousands 756,620 726,512 681,537 649,724 542,986 510,444 462,876 415,525 358,065 336,682 312,075 294,588 253,927 202,051 177,554 180,145 150,434 72,551
Total stockholders’ equity US$ in thousands 553,429 515,393 469,499 424,401 376,968 346,856 311,024 279,619 251,822 224,113 204,541 184,618 166,947 125,886 118,710 119,492 114,271 -91,250
Financial leverage ratio 1.37 1.41 1.45 1.53 1.44 1.47 1.49 1.49 1.42 1.50 1.53 1.60 1.52 1.61 1.50 1.51 1.32

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $756,620K ÷ $553,429K
= 1.37

The financial leverage ratio of Progyny Inc has demonstrated a consistent upward trend over the past eight quarters, increasing from 1.37 in Q4 2022 to 1.53 in Q1 2023, before slightly declining to 1.41 in Q3 2023. This ratio indicates that the company relies more on debt financing compared to equity to fund its operations and growth.

The ratio has mostly remained above 1, indicating that the company has more debt than equity in its capital structure. A financial leverage ratio above 1 suggests that the company is using debt to generate higher returns for its shareholders. However, a high financial leverage ratio also implies higher financial risk, as the company may struggle to meet its debt obligations in adverse economic conditions or if its cash flows decline.

Overall, Progyny Inc's financial leverage ratio has been relatively stable in recent quarters, but investors and stakeholders should continue to monitor it to ensure the company's debt levels remain sustainable and do not pose a significant risk to its financial health.


Peer comparison

Dec 31, 2023

Company name
Symbol
Financial leverage ratio
Progyny Inc
PGNY
1.37
DaVita HealthCare Partners Inc
DVA
16.00
Sotera Health Co
SHC
7.05